Indomethacin Use in Pain Relief During Intrauterine Device Insertion

Assiut University120 enrolled

Overview

The aim of the investigators study is to test the analgesic effect of rectal indomethacin during Intrauterine device insertion.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

TRIPLE

Enrollment

120

Conditions

Family Planning

Interventions

indomethacin suppositoriesDRUG

The patients will be instructed to self-administer a single rectal dose of 50 mg indomethacin 30 min before the scheduled time of the procedure

placeboDRUG

The patient swill be instructed to self-administer a single rectal dose of placebo 30 min before the scheduled time of the procedure

Eligibility

Sex: FEMALEMin age: 20 YearsMax age: 49 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Women not taken analgesics or anxiolytics in the 24 hours prior insertion * Women not taken misoprostol prior to intrauterine device insertion * Women who will accept to participate in the study Exclusion Criteria: * Any contraindication to intrauterine device placement

Locations (1)

Ahmed Abbas

Assiut, Cairo Governorate, Egypt

Outcomes

Primary Outcomes

Mean pain score during IUD insertion

Time frame: intraoperative

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.